| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | pregabalin (Lyrica®) |
| Formulation | 20 mg/ml oral solution |
| Reference number | 551 |
| Indication | Treatment of peripheral and central neuropathic pain in adults and as adjunctive therapy in adults with partial seizures with or without secondary generalisation and treatment of Generalised Anxiety Disorder (GAD) in adults |
| Company | Pfizer Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 25/11/2011 |